Pasithea Therapeutics Corp.
KTTA · XNASCIK 1841330fmd_03M5FEC3P61JV2M3VMQ5T07RRVManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2020 to Jun 30, 2026, 23 periods
AI-written
A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.
Loading